ArticleOncology reports2023

Exploring stage‑specific embryonic antigen 3 involvement in oral cancer progression and as a potential target for taxane‑based chemotherapy.

Kentaro Ide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.